Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma

NCT01055496 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, B-Cell

Interventions

DRUG: inotuzumab ozogamicin+rituximab +cyclophosphamide+vincristine+prednisone
DRUG: inotuzumab ozogamicin+rituximab+gemcitabine+cisplatinum+dexamethasone

Sponsor

Pfizer

Collaborators

[object Object]